News
GRMLW
0.3101
-31.39%
-0.1419
Weekly Report: what happened at GRMLW last week (1019-1023)?
Weekly Report · 6d ago
Weekly Report: what happened at GRMLW last week (1012-1016)?
Weekly Report · 10/19 09:42
Weekly Report: what happened at GRMLW last week (1005-1009)?
Weekly Report · 10/12 09:45
Weekly Report: what happened at GRMLW last week (0928-1002)?
Weekly Report · 10/05 09:44
Weekly Report: what happened at GRMLW last week (0921-0925)?
Weekly Report · 09/28 09:42
Weekly Report: what happened at GRMLW last week (0914-0918)?
Weekly Report · 09/21 09:42
Weekly Report: what happened at GRMLW last week (0907-0911)?
Weekly Report · 09/14 09:45
Weekly Report: what happened at GRMLW last week (0831-0904)?
Weekly Report · 09/07 09:41
Weekly Report: what happened at GRMLW last week (0824-0828)?
Weekly Report · 08/31 09:45
Weekly Report: what happened at GRMLW last week (0817-0821)?
Weekly Report · 08/24 09:45
Weekly Report: what happened at GRMLW last week (0810-0814)?
Weekly Report · 08/17 09:46
Weekly Report: what happened at GRMLW last week (0803-0807)?
Weekly Report · 08/10 09:43
Weekly Report: what happened at GRMLW last week (0727-0731)?
Weekly Report · 08/03 09:43
Weekly Report: what happened at GRMLW last week (0720-0724)?
Weekly Report · 07/27 09:45
Weekly Report: what happened at GRMLW last week (0713-0717)?
Weekly Report · 07/20 09:43
Weekly Report: what happened at GRMLW last week (0706-0710)?
Weekly Report · 07/13 09:44
Weekly Report: what happened at GRMLW last week (0629-0703)?
Weekly Report · 07/06 09:46
Weekly Report: what happened at GRMLW last week (0622-0626)?
Weekly Report · 06/29 09:43
Weekly Report: what happened at GRMLW last week (0615-0619)?
Weekly Report · 06/22 09:49
Weekly Report: what happened at GRMLW last week (0608-0612)?
Weekly Report · 06/15 09:49
More
Webull provides a variety of real-time GRMLW stock news. You can receive the latest news about Greenland Mines Ltd through multiple platforms. This information may help you make smarter investment decisions.
About GRMLW
ANEW Medical, Inc. is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The Company has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.